Immucell Corp.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Immucell Corp.
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
/ 
Frequently asked questions
To buy Immucell Corp. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Immucell Corp. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Immucell Corp. is ICCC:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Immucell Corp. has its primary listing on NASDAQ (Small cap). You can trade Immucell Corp. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Immucell Corp. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Immucell Corp. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Immucell Corp..